Physician profile
Harold Grafstein
NPI 1801842026
$308.41
in general payments reported to CMS, 2019-2025
9 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2022: $5.48 · 2023: $27.22 · 2024: $42.32 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $125.00 | 2019 | |
| Janssen Biotech, INC. | $42.30 | 2023-2024 | Simponi Aria, Stelara, Simponi |
| Pfizer INC. | $26.99 | 2025 | |
| Novo Nordisk INC | $23.69 | 2025 | Ozempic |
| Recordati_rare_diseases_inc. | $22.37 | 2025 | Isturisa |
| Merck Sharp & Dohme LLC | $20.63 | 2025 | Capvaxive, Verquvo |
| Organon LLC | $17.01 | 2022-2023 | Nexplanon |
| Exeltis, USA INC. | $15.71 | 2024 | Slynd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.71 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Grafstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.